Details
Stereochemistry | EPIMERIC |
Molecular Formula | C21H31NO2.ClH |
Molecular Weight | 365.937 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN(CC)CCCOC(=O)C1(C[C@@H]2CC[C@H]1C2)C3=CC=CC=C3
InChI
InChIKey=ODVPRPWQGNOPAY-PWITVKHSSA-N
InChI=1S/C21H31NO2.ClH/c1-3-22(4-2)13-8-14-24-20(23)21(18-9-6-5-7-10-18)16-17-11-12-19(21)15-17;/h5-7,9-10,17,19H,3-4,8,11-16H2,1-2H3;1H/t17-,19+,21?;/m1./s1
Molecular Formula | C21H31NO2 |
Molecular Weight | 329.4763 |
Charge | 0 |
Count |
|
Stereochemistry | EPIMERIC |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Bornaptine is a synthetic anticholinergic drug. The compound is a nonselective M1 and M4 antagonist and was shown to inhibit the negative inotropic response to carbachol in the isolated left atrium of the rat with pA2 of 7.27. Bornaprine is used for the treatment of symptoms of Parkinson's disease. A clinical trial showed the superiority of Bornaprine over placebo in reducing parkinsonian tremor. Bornaptine demonstrated positive results in localized hyperhidrosis.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:03:26 GMT 2023
by
admin
on
Fri Dec 15 17:03:26 GMT 2023
|
Record UNII |
R99RGW1B2Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID70949699
Created by
admin on Fri Dec 15 17:03:26 GMT 2023 , Edited by admin on Fri Dec 15 17:03:26 GMT 2023
|
PRIMARY | |||
|
248-100-5
Created by
admin on Fri Dec 15 17:03:26 GMT 2023 , Edited by admin on Fri Dec 15 17:03:26 GMT 2023
|
PRIMARY | |||
|
235767
Created by
admin on Fri Dec 15 17:03:26 GMT 2023 , Edited by admin on Fri Dec 15 17:03:26 GMT 2023
|
PRIMARY | RxNorm | ||
|
118984396
Created by
admin on Fri Dec 15 17:03:26 GMT 2023 , Edited by admin on Fri Dec 15 17:03:26 GMT 2023
|
PRIMARY | |||
|
26908-91-8
Created by
admin on Fri Dec 15 17:03:26 GMT 2023 , Edited by admin on Fri Dec 15 17:03:26 GMT 2023
|
PRIMARY | |||
|
100000091913
Created by
admin on Fri Dec 15 17:03:26 GMT 2023 , Edited by admin on Fri Dec 15 17:03:26 GMT 2023
|
PRIMARY | |||
|
C006088
Created by
admin on Fri Dec 15 17:03:26 GMT 2023 , Edited by admin on Fri Dec 15 17:03:26 GMT 2023
|
PRIMARY | |||
|
R99RGW1B2Q
Created by
admin on Fri Dec 15 17:03:26 GMT 2023 , Edited by admin on Fri Dec 15 17:03:26 GMT 2023
|
PRIMARY | |||
|
SUB00856MIG
Created by
admin on Fri Dec 15 17:03:26 GMT 2023 , Edited by admin on Fri Dec 15 17:03:26 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |